1-8 of 8
Alfonso Zaccaria, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tosedostat Plus Low Dose Cytarabine Induces a High Rate of Responses That Can be Predicted By Genetic Profiling in Elderly AML

Giuseppe Visani, MD, Federica Loscocco, PhD, Fabio Fuligni, Eliana Zuffa, MD, Alberto Sensi, MD, Alfonso Zaccaria, MD, Gerardo Musuraca, MD, Barbara Giannini, Alessandro Lucchesi, Francesca Fabbri, Anna Maria Mianulli, Patrizia Tosi, MD, Michela Tonelli, Anna Candoni, MD, Renato Fanin, Giovanni Sparaventi, Marco Gobbi, MD, Marino Clavio, Marco Rocchi, Pier Paolo Piccaluga, MD PhD, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2015) 126 (23): 329.
https://doi.org/10.1182/blood.V126.23.329.329
Published: 2015
Journal Articles

Lenalidomide Is Effective in Heavily Pretreated Non Hodgkin Lymphoma (NHL): Analysis of a Retrospective Data Collection

Luigi Rigacci, MD, Umberto Vitolo, M. Christina Cox, MD, Liliana Devizzi, MD, Alberto Fabbri, MD, Alfonso Zaccaria, MD, Francesco Zaja, MD, Paolo Paesano, MD, Giuseppe Rossi, MD, Sergio Storti, Sante Tura, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2012) 120 (21): 3694.
https://doi.org/10.1182/blood.V120.21.3694.3694
Published: 2012
Journal Articles

Fungal and Bacterial Infections in Acute Myeloid Leukemia Patients Treated with Induction Regimens Including Fludarabine: A Retrospective Analysis of 224 Cases.

Michele Malagola, MD, Annalisa Peli, MD, Daniela Damiani, MD, Anna Candoni, MD, Mario Tiribelli, MD, Giovanni Martinelli, MD, Pier Paolo Piccaluga, MD, Stefania Paolini, MD, Francesco Lauria, MD, Monica Bocchia, MD, Marco Gobbi, MD, Ivana Pierri, MD, Alfonso Zaccaria, MD, Eliana Zuffa, MD, Patrizio Mazza, MD, Giancarla Priccolo, MD, Luigi Gugliotta, MD, Alessandro Bonini, MD, Giuseppe Visani, MD, Skert Cristina, MD, Bergonzi Cesare, MD, Roccaro Aldo, MD, Fili Carla, MD, Renato Fanin, MD, Michele Baccarani, MD, Domenico Russo, MD
Journal: Blood
Blood (2007) 110 (11): 4351.
https://doi.org/10.1182/blood.V110.11.4351.4351
Published: 2007
Journal Articles

Hairy Cell Leukemias (HCL) with Unmutated V-Genes Have a Poorer Response to Single Agent 2CdA Than HCL with Mutated V-Genes.

Francesco Forconi, MD, DM, PhD, Elisa Sozzi, BSci, Donatella Raspadori, BSci, Francesca Toraldo, MD, Marzia Defina, MD, Francesco Zaja, MD, Luigi Rigacci, MD, Caterina Stelitano, MD, Andrea Gallamini, MD, Piero Galieni, MD, Tamara Intermesoli, MD, P.M. Stefani, MD, Alfonso Zaccaria, MD, Mariapia Lenoci, MD, Monica Bocchia, MD, Francesco Lauria, MD
Journal: Blood
Blood (2006) 108 (11): 2327.
https://doi.org/10.1182/blood.V108.11.2327.2327
Published: 2006
Journal Articles

A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, MD, PhD, Alessandro Pulsoni, MD, Manuela Balocco, MD, Monica Tani, MD, Stefano Fanti, MD, Alessio Perrotti, MD, Paolo Castellucci, MD, Francesco Zaja, MD, Alberto Fabbri, MD, Alfonso Zaccaria, MD, Maria Teresa Voso, MD, Pierpaolo Fattori, MD, Luciano Guardigni, MD, Patrizia Gentilini, MD, Maria Giuseppina Cabras, MD, Amalia De Renzo, MD, Luigi Rigacci, MD
Journal: Blood
Blood (2006) 108 (11): 2479.
https://doi.org/10.1182/blood.V108.11.2479.2479
Published: 2006
Journal Articles

Long Term Follow up on Patients with Ph-Abnormal Clones Emerged during Imatinib Therapy.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Nicoletta Testoni, PhD, Alfonso Zaccaria, MD, Franca Radaelli, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Federica Sora’, MD, Monica Crugnola, MD, Michele Cedrone, MD, Gianantonio Rosti, MD, Sergio Amadori, MD, Paolo de Fabritiis, MD, Michele Baccarani, MD
Journal: Blood
Blood (2006) 108 (11): 2116.
https://doi.org/10.1182/blood.V108.11.2116.2116
Published: 2006
Journal Articles

Fludarabine Based Regimen (FLAI) Is an Effective Treatment for Induction of Multidrug Resistant Pgp-Positive Acute Myeloid Leukemia Patients.

Domenico Russo, MD, Daniela Damiani, MD, Michele Malagola, MD, Antonio De Vivo, MD, Mauro Fiacchini, MD, Giovanni Martinelli, MD, Pier Paolo Piccaluga, MD, Anna Candoni, MD, Angela Michelutti, MD, Renato Fanin, MD, Maurizio Castelli, MD, Nicoletta Testoni, MD, Emanuela Ottaviani, MD, Michela Rondoni, MD, Giancarla Pricolo, MD, Patrizio Mazza, MD, Eliana Zuffa, MD, Alfonso Zaccaria, MD, Donatella Raspadori, MD, Monica Bocchia, MD, Francesco Lauria, MD, Alessandro Bonini, MD, Paolo Avanzini, MD, Luigi Gugliotta, MD, Ivana Pierri, MD, Marco Gobbi, MD, Giuseppe Visani, MD, Michele Baccarani, MD
Journal: Blood
Blood (2005) 106 (11): 1857.
https://doi.org/10.1182/blood.V106.11.1857.1857
Published: 2005
Journal Articles

Ph-Abnormal Clones Emerged during Imatinib Therapy: Clinical Report and Clonal Analyses on 23 Patients from GIMEMA Working Party (GWP) in CML Registry.

Elisabetta Abruzzese, MD, Alessandro Gozzetti, MD, Alfonso Zaccaria, MD, Nicoletta Testoni, MD, Sara Galimberti, MD, Malgorzata M. Trawinska, MD, Tommaso Caravita, MD, Paola Panetta, BS, Marco Mancini, MD, Dario Ferrero, MD, Michela Salvio, MD, Franca Radaelli, MD, Federica Sora’, MD, Gianantonio Rosti, Sergio Amadori, MD, Michele Baccarani, MD
Journal: Blood
Blood (2004) 104 (11): 2936.
https://doi.org/10.1182/blood.V104.11.2936.2936
Published: 2004